Search - tctmd.com

Displaying 381 - 400 of 2033

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2022

Shelley Wood

February 28, 2022

News Daily News

FDA Approves Empagliflozin for Treatment of HFpEF

Michael O'Riordan

February 24, 2022

News Daily News

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

Shelley Wood

February 22, 2022

News Daily News

What Can Lp(a) Add to CAC for ASCVD Risk Prediction? New Insights

Yael L. Maxwell

February 22, 2022

News Daily News

Robert M. Califf Becomes 25th Commissioner of the US FDA

L.A. McKeown

February 15, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for February Week 2

Todd Neale

February 07, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Opinion Fellow Talk

A Trainee’s Perspective on the First Genetically Engineered Pig-to-Human Cardiac Xenotransplantation

Corbin E. Goerlich, MD

January 13, 2022

News Opinion Editor's Corner

The Biggest News of 2021: TCTMD’s Top 10

Shelley Wood

December 30, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2021

Caitlin E. Cox

December 29, 2021

News Daily News

COVID-19: TCTMD’s Dispatch for December Week 4

Todd Neale

December 27, 2021

News Daily News

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

Michael O'Riordan

December 22, 2021

News Daily News

FDA Approves Two Additional Indications for Rivaroxaban in Children

L.A. McKeown

December 21, 2021

News Daily News

FDA Clears SAPIEN 3 With Alterra Prestent for Pulmonary Valve Replacement

L.A. McKeown

December 20, 2021

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

News Daily News

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

Michael O'Riordan

December 09, 2021

News Daily News

COVID-19: TCTMD’s Dispatch for December Week 1

Todd Neale

December 06, 2021

News Daily News

Penumbra’s JET 7 Recall: A Kick Start to Change?

Caitlin E. Cox

December 01, 2021

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Michael O'Riordan

November 26, 2021

News Conference News PCR London Valves 2021

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

Michael O'Riordan

November 25, 2021

Advertisement

TCTMD’s Top 10 Most Popular Stories for February 2022

FDA Approves Empagliflozin for Treatment of HFpEF

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

What Can Lp(a) Add to CAC for ASCVD Risk Prediction? New Insights

Robert M. Califf Becomes 25th Commissioner of the US FDA

COVID-19: TCTMD’s Dispatch for February Week 2

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

A Trainee’s Perspective on the First Genetically Engineered Pig-to-Human Cardiac Xenotransplantation

The Biggest News of 2021: TCTMD’s Top 10

TCTMD’s Top 10 Most Popular Stories for December 2021

COVID-19: TCTMD’s Dispatch for December Week 4

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

FDA Approves Two Additional Indications for Rivaroxaban in Children

FDA Clears SAPIEN 3 With Alterra Prestent for Pulmonary Valve Replacement

British Medical Groups Express Concern About Inclisiran Rollout

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

COVID-19: TCTMD’s Dispatch for December Week 1

Penumbra’s JET 7 Recall: A Kick Start to Change?

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content